Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of secondary hyperparathyroidism in uremic patients
2006-005981-37Phase 4Terminated
- Sponsor
- Zealand University Hospital, Roskilde
- Start
- Nov 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alfacalcidol and paricalcitol in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Zealand University Hospital, Roskilde. Started Nov 2006; status: terminated.
02
Drugs
alfacalcidolparicalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2006-005981-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005981-37.